Biotech News
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results
investors.embecta.com2026-05-06 14:47 EST
PARSIPPANY, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported first quarter fiscal 2026 financial results.